"Smart teams will do amazing things, but truly diverse teams will do impossible things"
~ Claudia Brind Woody
About Us
Who We Are ?
We are a group of experts experienced in health economics and outcomes research, market access, clinical research and medical communications.
Our team of researchers provide evidence solutions from a range of perspectives thereby, delivering a robust, customized, engaging and reliable solutions to our clients.
Why Choose Us ?
- Subject area experts, each with 8+ years of experience in pharmaceutical product development, regulatory, HEOR and/or market access strategies.
- Vast experience in working across multiple therapeutic areas including oncology, metabolic, cardiovascular, respiratory, neurological, auto-immune, renal and gastrointestinal disorders, infectious disease and rare conditions.
- Customized, cost-effective solutions from a range of perspectives tailored for each project.
- Achieve tight targets while operating within client’s systems and procedures.
- Thorough in-house scientific, editorial and quality control review prior to the sponsor review.
-
Rohini Sharma, M.S. (Pharm.) Pharmacology and Toxiclogy, MBA, PhDc
Valuecom Evidence Based Solutions is managed by Rohini Sharma, a health outcomes expert with more than 14 years of experience in health economics and outcomes research, market access, regulatory writing and clinical research. She has global expertise in health technology assessments and have supported clients with regulatory and reimbursement submissions to agencies in North America, Europe, and Asia-Pacific, in a wide-variety of therapeutic areas.
Our Vision
To be a valued consulting partner to our clients, sharing the common goal of addressing unmet medical needs and making a difference in patient’s lives.
Our Mission
We aspire to collaborate with forward-thinking clients to provide insightful, high-quality and cost-effective services. This will be evident from our wealth of expertise in working across multiple therapeutic areas, our team’s in-depth understanding of the complex drug development process, our passion for our work and our commitment to deliver best-in-class services that support our clientele’s vision.